Skip to content

BioZorb Marker F0202Recalls & reported problems

Focal Therapeutics, Inc. · The Marker is a radiographic implantable marker used to mark soft tissue. It is comprised of a bioabsorbable spacer that holds radiopaque marker clips. · Class 2 · Implant

All models of BioZorb Marker (6)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
9
Deaths reported
0
Injuries reported
9
Recalls naming it
0

Summary

The FDA's MAUDE database contains 9 adverse event reports that list this exact device (DI 00851766006009), received between Sep 5, 2023 and Mar 20, 2026 — classified as 9 injuries.

The most frequently reported specific device problem is “Migration” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 2 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 1 reportsMar 2025: 2 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 1 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem7
  • Migration2
  • Detachment of Device or Device Component1

Patient problems

  • Breast Discomfort/Pain5
  • Erythema4
  • Breast Mass3
  • Deformity/ Disfigurement3
  • Itching Sensation3
  • Seroma3
  • Swelling/ Edema3
  • Rash2

Recent adverse event reports

The 9 most recent of 9 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 20, 2026

    I RECEIVED THE BIOZORB WHILE HAVING A LUMPECTOMY FOR MALIGNANT DUCTAL CARCINOMA OF THE RIGHT BREAST. SHORTLY AFTER SURGERY BEGAN HAVING DISCOMFORT AND WAS TOLD OVER AND OVER THAT THE IMPLANT WOULD DISSOLVE. FAST FORWARD TO TODAY (B)(6) 2026 I HAVE SWELLING, PAIN, DISFIGURATION AS WELL AS RASH IN THE AREA. RECENT MAMMOGRAM REVEALS IT IS STILL COMPLETELY INTACT. SCHEDULED FOR REMOVAL (B)(6) 2026.

    Patient problems: Deformity/ Disfigurement; Discomfort; Pain; Rash; Swelling/ Edema

    MAUDE report 24649215 ↗
  • InjurySep 30, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT A PATIENT RECEIVED A BIOZORB DEVICE IMPLANT ON (B)(6) 2019. IT WAS FURTHER REPORTED THAT THE PATIENT HAS EXPERIENCED INJURIES AT AND AROUND THE SITE OF IMPLANTATION, WHICH INCLUDE PAIN, TENDERNESS, SENSITIVITY, A HARD MASS AND FAILURE TO REABSORB. NO FURTHER INFORMATION IS CURRENTLY AVAILABLE.

    Patient problems: Breast Discomfort/Pain; Breast Mass; Deformity/ Disfigurement

    MAUDE report 23179264 ↗
  • InjuryMar 16, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THE PATIENT HAD A LUMPECTOMY WITH BIOZORB PLACEMENT ON (B)(6) 2017. THE PATIENT RETURNED FOR A REQUIRED RE-EXCISION AND WAS THEN FOUND TO HAVE A PSEUDOMONAS INFECTION. THE PATIENT WAS TREATED AND HEALED.

    Patient problems: Bacterial Infection

    MAUDE report 21615639 ↗
  • InjuryMar 16, 2025Detachment of Device or Device Component; Migration; Detachment of Device or Device Component; Migration

    IT WAS REPORTED THAT THE PATIENT HAD A LUMPECTOMY WITH BIOZORB PLACEMENT ON (B)(6) 2016. A RE-EXCISION DUE TO POSITIVE MARGINS WAS PERFORMED ON (B)(6) 2017 WHERE THE BIOZORB WAS REMOVED AND PLACED BACK IN AFTER RE-EXCISION. ON (B)(6) 2017 A CT SCAN SHOWED THE BIOZORB INTACT. A SECOND CT SCAN COMPLETED ON (B)(6) 2017 SHOWED THE BIOZORB IN TWO SEPARATE PIECES, HALF OF IT WAS IN THE TUMOR BED AND THE OTHER MIGRATED OUT INTO SEROMA. NO MEDICAL OR SURGICAL INTERVENTION WAS REPORTED.

    Patient problems: Device Embedded In Tissue or Plaque; Seroma

    MAUDE report 21615638 ↗
  • InjuryFeb 5, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THE PATIENT HAD A LUMPECTOMY WITH BIOZORB PLACEMENT ON (B)(6) 2016. APPROXIMATELY 5 WEEKS AFTER SURGERY THE PATIENT PRESENTED WITH SWOLLEN, PUFFY, AND RED BREAST WITH MILD SEROUS DRAINAGE. SEROUS FLUID CULTURE GREW STAPHYLOCOCCUS AUREUS. THE PATIENT WAS TREATED WITH ANTIBIOTICS AND AS OF (B)(6) 2016, THE PATIENT WAS IMPROVING. THE BIOZORB DEVICE WAS LEFT IN PLACE.

    Patient problems: Erythema; Inflammation; Seroma; Swelling/ Edema

    MAUDE report 21312399 ↗
  • InjuryNov 22, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT ON (B)(6) 2021 A BIOZORB WAS IMPLANTED, AND THE PATIENT REPORTED SUFFERING FROM A HARD, PAINFUL LUMP NEAR THE SITE OF THE BIOZORB DEVICE. THE PATIENT ALSO REPORTED SUFFERING FROM SWELLING, DISCOMFORT, PAIN, ITCHING, AND A BURNING SENSATION AT AND AROUND THE SITE OF THE BIOZORB DEVICE. THE PATIENT ALSO REPORTED BELIEVING THAT THE BIOZORB DEVICE HAS FAILED TO PROPERLY ABSORB. NO ADDITIONAL INFORMATION AVAILABLE.

    Patient problems: Breast Discomfort/Pain; Breast Mass; Burning Sensation; Itching Sensation

    MAUDE report 18191507 ↗
  • InjuryNov 9, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT ON (B)(6) 2019, A BIOZORB WAS IMPLANTED, AND THE PATIENT REPORTED SUFFERING FROM A HARD, PAINFUL LUMP NEAR THE SITE WHERE THE BIOZORB DEVICE WAS IMPLANTED, DEFORMITY, SCARRING, AND REDDENING OF THE SKIN WHERE THE BIOZORB DEVICE WAS IMPLANTED. THE PATIENT REPORTED ALSO SUFFERING FROM SENSITIVITY, ITCHING, SWELLING, AND PAIN THAT MAKE SLEEPING DIFFICULT AND MAMMOGRAMS SEVERELY PAINFUL. NO ADDITIONAL INFORMATION AVAILABLE.

    Patient problems: Breast Discomfort/Pain; Deformity/ Disfigurement; Erythema; Itching Sensation

    MAUDE report 18105569 ↗
  • InjuryOct 27, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT A PATIENT RECEIVED A BIOZORB IMPLANTATION ON (B)(6) 2019. THE PATIENT REPORTED THAT SHE SUFFERS FROM A HARD, PAINFUL LUMP AT THE SITE OF IMPLANTATION. ADDITIONAL PATIENT REPORTED THAT SHE SUFFERS FROM SWELLING, INFECTIONS, TENDERNESS, DEFORMITY, AND PAIN THAT AFFECTS HER DAILY LIFE INCLUDING DIFFICULTY TO SLEEP. NO OTHER INFORMATION IS AVAILABLE.

    Patient problems: Breast Discomfort/Pain; Breast Mass; Erythema; Seroma; Sleep Dysfunction; Swelling/ Edema

    MAUDE report 18025677 ↗
  • InjurySep 5, 2023Adverse Event Without Identified Device or Use Problem; Migration; Adverse Event Without Identified Device or Use Problem; Migration

    IT WAS REPORTED THAT ON (B)(6) 2018, A BIOZORB WAS IMPLANTED IN A PATIENT AND THE PATIENT REPORTED SUFFERING FROM A LUMP IN HER LEFT BREAST IN THE AREA OF THE BIOZORB, WHICH HAD MIGRATED FROM ITS ORIGINAL LOCATION. IT WAS REPORTED THAT THE BIOZORB CAUSES CONSTANT ITCHING, RASHES, STABBING PAIN, AND DISCOMFORT. THE PATIENT REPORTED THAT HAS DISCUSSED EXPLANT SURGERY OF BIOZORB BUT IS HESITANT TO GO THROUGH ANOTHER SURGERY. NO ADDITIONAL INFORMATION AVAILABLE.

    Patient problems: Breast Discomfort/Pain; Erythema; Itching Sensation; Rash; Sleep Dysfunction

    MAUDE report 17686248 ↗

Other Marker, Radiographic, Implantable devices

All Marker, Radiographic, Implantable devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page